Company registration number 07805399 (England and Wales)
CERIDEN HEALTHCARE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
CERIDEN HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 7
CERIDEN HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
2,290
-
0
Current assets
Debtors
6
181
10,879
Cash at bank and in hand
174
174
355
11,053
Creditors: amounts falling due within one year
7
(20,108)
(23,980)
Net current liabilities
(19,753)
(12,927)
Net liabilities
(17,463)
(12,927)
Capital and reserves
Called up share capital
8
554,300
554,300
Profit and loss reserves
(571,763)
(567,227)
Total equity
(17,463)
(12,927)

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
Mr A Baporia
Director
Company registration number 07805399 (England and Wales)
CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Ceriden Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Gateway House (First Floor), 324 Regents Park Road, London, N3 2LN.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements have been prepared on the going concern basis.

In arriving at their conclusion on the going concern status of the business, management have considered the company's financial position and given careful attention to its net current liability position at the balance sheet date. Having reviewed the company's financial forecasts and expected future cash flows, the directors have a reasonable expectation that the company has adequate resources available to it to continue in operational existence for the foreseeable future, a period of not less than 12 months from the date of signing of these financial statements.

The company meets its day to day working capital requirements facilities provided by its stakeholders. Existing shareholders are willing to provide further financial support as they have done in the past.

Based on this, the directors believe that it remains appropriate to prepare its financial statements on a going concern basis. These financial statements do not include any adjustments that would result from the basis of preparation being inappropriate.

1.3
Turnover

Turnover represents provision of services in relation to care home services. Income is recognised on the day the service is provided.

1.4
Intangible fixed assets - goodwill

Goodwill is the difference between the amounts paid on the acquisition of a business and the fair value of the identifiable assets and liabilities acquired. It is amortised to the profit and loss account over its estimated economic life of 10 years.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
33.3% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Derivatives

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
554,300
Amortisation and impairment
At 1 April 2024 and 31 March 2025
554,300
Carrying amount
At 31 March 2025
-
0
At 31 March 2024
-
0
5
Tangible fixed assets
Fixtures and fittings
£
Cost
At 1 April 2024
336,508
Additions
2,290
At 31 March 2025
338,798
Depreciation and impairment
At 1 April 2024 and 31 March 2025
336,508
Carrying amount
At 31 March 2025
2,290
At 31 March 2024
-
0
CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Corporation tax recoverable
-
0
3,669
Other debtors
181
7,210
181
10,879
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
0
4,925
Other creditors
20,108
19,055
20,108
23,980
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
554,300
554,300
554,300
554,300
9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Asif Hassan
Statutory Auditor:
Taylor Associates
Date of audit report:
23 December 2025
10
Related party transactions

The directors have chosen to take advantage of the disclosure requirement of section 1A of FRS 102, which allows the company not to disclose transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly-owned by such a member.

CERIDEN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
11
Parent company

At the year end, the immediate parent company was St. Agnes Limited, a company registered in Gibraltar. The ultimate parent company is St. Agnes Limited, a company registered in Gibraltar.

2025-03-312024-04-01falsefalsefalse23 December 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr A BaporiaMrs S KanoriaMr A Baporia078053992024-04-012025-03-31078053992025-03-31078053992024-03-3107805399core:FurnitureFittings2025-03-3107805399core:FurnitureFittings2024-03-3107805399core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3107805399core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3107805399core:ShareCapital2025-03-3107805399core:ShareCapital2024-03-3107805399core:RetainedEarningsAccumulatedLosses2025-03-3107805399core:RetainedEarningsAccumulatedLosses2024-03-3107805399core:ShareCapitalOrdinaryShareClass12025-03-3107805399core:ShareCapitalOrdinaryShareClass12024-03-3107805399bus:CompanySecretaryDirector12024-04-012025-03-3107805399core:Goodwill2024-04-012025-03-3107805399core:FurnitureFittings2024-04-012025-03-31078053992023-04-012024-03-3107805399core:NetGoodwill2024-03-3107805399core:NetGoodwill2025-03-3107805399core:NetGoodwill2024-03-3107805399core:FurnitureFittings2024-03-3107805399core:CurrentFinancialInstruments2025-03-3107805399core:CurrentFinancialInstruments2024-03-3107805399core:WithinOneYear2025-03-3107805399core:WithinOneYear2024-03-3107805399bus:OrdinaryShareClass12024-04-012025-03-3107805399bus:OrdinaryShareClass12025-03-3107805399bus:OrdinaryShareClass12024-03-3107805399bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107805399bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107805399bus:FRS1022024-04-012025-03-3107805399bus:Audited2024-04-012025-03-3107805399bus:Director12024-04-012025-03-3107805399bus:Director22024-04-012025-03-3107805399bus:CompanySecretary12024-04-012025-03-3107805399bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP